Oncodisc, Inc. (now dba Veris Health) operates as part of PAVmed Inc a highly differentiated Nasdaq-listed, multi-product, commercial-stage medical technology company with a diversified product pipeline. Almost immediately on founding, principals of the firm were able to raise a non-trivial level of seed capital. The firm was/is discussed as addressing unmet clinical needs by encompassing a broad spectrum of clinical areas with attractive regulatory pathways and market opportunities: developing data-driven, remote care technology. Founded - and structured - around technology designed to benefit cancer and chronic disease patients by providing artificial intelligence-embedded, physician-designed software integrated with intelligent vascular access technology, the defined mission of OncoDisc (Veris Health) was described as "personalizing care" through remote detection of changes in patient health status and enhance doctor-patient communication. In June 2021, the firm was acquired by PAVmed
